Polydactyly and hypertension.
A case diagnosed as Bardet-Biedl syndrome with polydactyly and hypertension has been presented here. Bardet-Biedl syndrome is an autosomal recessive disorder, which includes renal dystrophy, dystrophic extremities (often polydactyly), obesity, hypogenitalism, renal disease, and mental retardation. It was first described by John Z. Laurence and Robert Moon. The basic components of the syndrome were established by George Bardet in 1920 and Arthur Biedl in 1922. Although it is still referred to as Laurence-Moon-Bardet-Biedl in some reports, it has recently acquired the name Bardet-Biedl syndrome. Patients were generally lost due to renal insufficiency at young ages.
Isik
Daghan
D
Plastic and Reconstructive Surgery Clinic, Gaziantep Avukat Cengiz Gökcek State Hospital, Gaziantep, Turkey. daghanmd@yahoo.co.uk
Bulut
Omer
O
Sunay
Mahmut
M
Bekerecioglu
Mehmet
M
D000959:Antihypertensive Agents / Q000627:therapeutic use; D020788:Bardet-Biedl Syndrome / Q000175:diagnosis; D002216:Captopril / Q000627:therapeutic use; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005385:Fingers / Q000002:abnormalities* / Q000601:surgery*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D007986:Luteinizing Hormone / Q000097:blood / Q000172:deficiency; D008297:Male; D017689:Polydactyly / Q000150:complications* / Q000601:surgery*; D013739:Testosterone / Q000097:blood / Q000172:deficiency; D014034:Toes / Q000002:abnormalities* / Q000601:surgery*
D000959:Antihypertensive Agents; D013739:Testosterone; D007986:Luteinizing Hormone; D002216:Captopril